BIA responds to the newly announced NHS England/Novartis deal
Commenting on the new NHS England/Novartis deal and the publication of the new UK life sciences sector update announced at JP Morgan today, Steve Bates OBE, Chief Executive of the BioIndustry Association said:
"Global players are announcing the UK as their destination of choice for innovation at this year’s JP Morgan Healthcare conference. They recognise the value of partnering with our integrated and highly innovative ecosystem. The hard work put into delivering the UK Life Sciences Industrial strategy is paying off and today’s update document shows just how much progress there has been in recent months. It’s great that Novartis sees the UK as an innovation crucible for access, clinical trials and next generation manufacturing.”
Notes to Editors
1. For more information please contact Jack Fellows, Communications and Media Manager on firstname.lastname@example.org or 07825942934
2. The Life Sciences Industrial Strategy Update can be found here: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/857348/Life_sciences_industrial_strategy_update.pdf
About the BIA
Established over 25 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative life sciences in the UK. Our goal is to secure the UK's position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people's lives.